Business Description
Haleon PLC
ISIN : US4055521003
Share Class Description:
HLN: ADRCompare
Compare
Traded in other countries / regions
HLN.UKHLN.USAH6D0.GermanyHLN1.Mexico IPO Date
2022-07-18Description
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 4.44 | |||||
Interest Coverage | 4.46 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.77 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.4 | |||||
3-Year EBITDA Growth Rate | 7.1 | |||||
3-Year EPS without NRI Growth Rate | 1.2 | |||||
3-Year FCF Growth Rate | 17.2 | |||||
3-Year Book Growth Rate | -14 | |||||
Future 3-5Y EPS without NRI Growth Rate | 7.35 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.27 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 81.24 | |||||
9-Day RSI | 75.83 | |||||
14-Day RSI | 71.41 | |||||
6-1 Month Momentum % | 6.06 | |||||
12-1 Month Momentum % | -2.06 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.21 | |||||
Days Inventory | 115.35 | |||||
Days Sales Outstanding | 52.89 | |||||
Days Payable | 195.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.66 | |||||
Dividend Payout Ratio | 0.52 | |||||
Forward Dividend Yield % | 2.32 | |||||
5-Year Yield-on-Cost % | 1.66 | |||||
Shareholder Yield % | 3.93 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.04 | |||||
Operating Margin % | 18.02 | |||||
Net Margin % | 9.64 | |||||
FCF Margin % | 15.78 | |||||
ROE % | 6.58 | |||||
ROA % | 3.15 | |||||
ROIC % | 4.41 | |||||
ROC (Joel Greenblatt) % | 113.14 | |||||
ROCE % | 7.18 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.18 | |||||
Forward PE Ratio | 19.88 | |||||
PE Ratio without NRI | 31.39 | |||||
Price-to-Owner-Earnings | 20.27 | |||||
PS Ratio | 2.8 | |||||
PB Ratio | 1.96 | |||||
Price-to-Free-Cash-Flow | 18.04 | |||||
Price-to-Operating-Cash-Flow | 15.12 | |||||
EV-to-EBIT | 19.92 | |||||
EV-to-Forward-EBIT | 17.6 | |||||
EV-to-EBITDA | 19.92 | |||||
EV-to-Forward-EBITDA | 15.53 | |||||
EV-to-Revenue | 3.78 | |||||
EV-to-Forward-Revenue | 3.5 | |||||
EV-to-FCF | 22.83 | |||||
Earnings Yield (Greenblatt) % | 5.02 | |||||
FCF Yield % | 5.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:HLN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Haleon PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 14,147.906 | ||
EPS (TTM) ($) | 0.296 | ||
Beta | 0 | ||
Volatility % | 12.73 | ||
14-Day RSI | 71.41 | ||
14-Day ATR ($) | 0.122686 | ||
20-Day SMA ($) | 8.6985 | ||
12-1 Month Momentum % | -2.06 | ||
52-Week Range ($) | 7.695 - 9.28 | ||
Shares Outstanding (Mil) | 4,566.15 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Haleon PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Haleon PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Haleon PLC Frequently Asked Questions
What is Haleon PLC(HLN)'s stock price today?
The current price of HLN is $9.23. The 52 week high of HLN is $9.28 and 52 week low is $7.70.
When is next earnings date of Haleon PLC(HLN)?
The next earnings date of Haleon PLC(HLN) is 2024-08-02 Est..
Does Haleon PLC(HLN) pay dividends? If so, how much?
The Dividend Yield %  of Haleon PLC(HLN) is 1.66% (As of Today), Highest Dividend Payout Ratio of Haleon PLC(HLN) was 0.52. The lowest was 0.24. And the median was 0.24. The  Forward Dividend Yield % of Haleon PLC(HLN) is 2.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |